|
|
 |
|
 |
February 01, 2005
MDX Medical Inc. Announces Strategic Marketing Campaign
For Immediate Release
Vancouver, BC February 1, 2005 - MDX Medical Inc. (TSX.V:MDX) announced today implementation of a novel and aggressive marketing campaign to the US market to further support launch of the AVID System. The marketing campaign will allow medical physicists to assess Version 1.1 of the AVID Image Analysis Software in their own clinic for up to 30 days, comparing against current methods and procedures.
Version 1.1 differs from the original AVID System Image Analysis Software launched in the fall of 2004 offering compatibility with virtually all existing phantom hardware in the IMRT (Intensity Modulated Radiation Therapy) clinic.
MDX Medical President, Mr. Mark Thomson stated, "Not only can we offer medical physicists the AVID System as an integrated QA solution for the IMRT clinic, but are now able to market our superior software package to the entire IMRT market as a stand-alone upgrade."
Development of Version 1.1 of the AVID Image Analysis Software resulted from direct discussions with medical physicists at the AAPM and ASTRO conferences in late 2004, as well as identification of several needs within the IMRT treatment planning QA market.
Mr. Thomson further stated, "Our marketing campaign creates a tremendous opportunity for the company to develop strong relationships within the medical physicist community allowing for additional sales of the AVID phantom, given its unique capabilities for the IMRT clinic."
About MDX Medical
MDX is focused on commercializing innovative and leading-edge medical device technologies for improved diagnosis and treatment of cancer and other life-threatening diseases. The Company�s business strategy is to acquire promising technologies that have reached the "proof of feasibility" or later stages of product development, complete the final stages of commercialization, obtain the required regulatory approvals and pursue strategic marketingpartners. For more information about MDX, please visit our website at: www.mdxmedical.com
On behalf of the Board,
"Mark Thomson"
President, MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Larry Horsburgh
Phone: (604) 694-7770, Ext. 112
Email: lhorsburgh@mdxmedical.com |
|  |
|
